Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Piezo1 Possible Key to Supporting Muscle Regeneration in Duchenne Muscular Dystrophy - Penn Medicine
Todd Dubnicoff The Stem Cellar
Pathway Behind Muscle Breakdowns in Duchenne Muscular Dystrophy Discovered - Penn Medicine
Muscle and peripheral nerve pathology (Chapter 45) - Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
Progression of DMD and its complications. Duchenne muscular
Duchenne muscular dystrophy, The Stem Cellar
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Stem Cell Stories that Caught Our Eye: Killer Cells May Treat
